165 related articles for article (PubMed ID: 17921589)
1. Biologically-equivalent dose and long-term survival time in radiation treatments.
Zaider M; Hanin L
Phys Med Biol; 2007 Oct; 52(20):6355-62. PubMed ID: 17921589
[TBL] [Abstract][Full Text] [Related]
2. The influence of repopulation kinetics on isoeffect doses for permanent implants.
Kneschaurek P
Strahlenther Onkol; 1994 Oct; 170(10):602-7. PubMed ID: 7974172
[TBL] [Abstract][Full Text] [Related]
3. Probability dynamics of a repopulating tumor in case of fractionated external radiotherapy.
Stavreva N; Stavrev P; Fallone BG
Phys Med; 2009 Dec; 25(4):181-91. PubMed ID: 19345599
[TBL] [Abstract][Full Text] [Related]
4. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
[TBL] [Abstract][Full Text] [Related]
5. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle times and the tumour control probability.
Maler A; Lutscher F
Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
[TBL] [Abstract][Full Text] [Related]
7. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population.
Roeske JC; Stinchcomb TG
Phys Med Biol; 2006 May; 51(9):N179-86. PubMed ID: 16625028
[TBL] [Abstract][Full Text] [Related]
8. Limitations of a TCP model incorporating population heterogeneity.
Warkentin B; Stavrev P; Stavreva NA; Fallone BG
Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
[TBL] [Abstract][Full Text] [Related]
9. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
Gay HA; Jin JY; Chang AJ; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
[TBL] [Abstract][Full Text] [Related]
10. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
11. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
[TBL] [Abstract][Full Text] [Related]
12. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
Fowler JF
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model.
Zhou SM; Das S; Wang Z; Marks LB
Med Phys; 2004 Sep; 31(9):2606-9. PubMed ID: 15487743
[TBL] [Abstract][Full Text] [Related]
15. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
Armpilia C; Dale RG; Sandilos P; Vlachos L
Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry in nuclear medicine therapy: radiobiology application and results.
Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
[TBL] [Abstract][Full Text] [Related]
17. Application of the linear-quadratic model to combined modality radiotherapy.
Bodey RK; Evans PM; Flux GD
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):228-41. PubMed ID: 15093920
[TBL] [Abstract][Full Text] [Related]
18. Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1538-43. PubMed ID: 18786779
[TBL] [Abstract][Full Text] [Related]
19. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
[TBL] [Abstract][Full Text] [Related]
20. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?
Tucker SL; Thames HD; Taylor JM
Radiat Res; 1990 Dec; 124(3):273-82. PubMed ID: 2263727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]